Tenax Therapeutics (TENX) EBIT Margin (2010 - 2015)

Tenax Therapeutics recorded quarterly EBIT Margin of 9874.97% in Q2 2015, down 1346.87% quarter-over-quarter from 682.51% in Q2 2013.

Tenax Therapeutics' EBIT Margin history runs 5 years deep, the most recent figure standing at 9874.97% for Q2 2015.

  • In Q2 2015, EBIT Margin changed N/A year-over-year to 9874.97%; the TTM figure through Jun 2016 stood at 29548.27% (down 2868141.0% YoY), while the FY2015 annual figure was 6945.4%, changed N/A from the prior year.
  • EBIT Margin came in at 9874.97% for Q2 2015 at Tenax Therapeutics, down from 682.51% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 10360.51% in Q1 2011 to a low of 9874.97% in Q2 2015.
  • A 4-year average of 980.33% and a median of 719.97% in 2013 frame the typical range for EBIT Margin.
  • On a YoY basis, EBIT Margin climbed as much as 914614 bps in 2012 and fell as far as 1164303 bps in 2012.
  • Tenax Therapeutics' EBIT Margin stood at 2158.73% in 2011, then soared by 94 bps to 132.62% in 2012, then plunged by 415 bps to 682.51% in 2013, then slumped by 1347 bps to 9874.97% in 2015.
  • According to Business Quant data, EBIT Margin over the past three periods registered 9874.97%, 682.51%, and 719.97% for Q2 2015, Q2 2013, and Q1 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.02%
10 Tenax Therapeutics 542.72 Mn 542.72 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2015 -9,874.97%
Apr 30, 2013 -682.51%
Jan 31, 2013 -719.97%
Oct 31, 2012 -132.62%
Jul 31, 2012 -615.75%
Apr 30, 2012 -2,067.33%
Jan 31, 2012 -1,282.52%
Oct 31, 2011 -2,158.73%
Jul 31, 2011 -9,761.90%
Apr 30, 2011 6,152.14%
Jan 31, 2011 10,360.51%
Oct 31, 2010 7,582.16%